| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0361-9230(03)00071-6 |
| P698 | PubMed publication ID | 15036556 |
| P50 | author | Yaniv Barkana | Q70958076 |
| P2093 | author name string | Michael Belkin | |
| P2860 | cites work | Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation | Q31049320 |
| Neuroprotective therapy for argon-laser induced retinal injury | Q32124308 | ||
| The effect of high-dose methylprednisolone on laser-induced retinal injury in primates: an electron microscopic study | Q32170262 | ||
| Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative myopia | Q33262725 | ||
| Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801 | Q33645648 | ||
| Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma | Q33693579 | ||
| Evaluation of memantine for neuroprotection in dementia | Q34074926 | ||
| Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy | Q34486849 | ||
| Glutamate neurotoxicity and diseases of the nervous system | Q34560997 | ||
| Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma | Q34734517 | ||
| Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells | Q35063857 | ||
| T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies | Q35160575 | ||
| Pharmacological strategies in CNS trauma | Q35225753 | ||
| Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate | Q35588333 | ||
| Structural aspects of laser-induced damage and their functional implications | Q35826229 | ||
| Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma | Q36440373 | ||
| Laser-induced primate glaucoma. I. Progression of cupping | Q36612626 | ||
| Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve | Q74819296 | ||
| Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia | Q77510870 | ||
| Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina | Q78202522 | ||
| Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate | Q93647550 | ||
| Laser-induced primate glaucoma. II. Histopathology | Q36612632 | ||
| Clinicopathologic correlation of laser lesion expansion after treatment of choroidal neovascularization. | Q36673991 | ||
| Methylprednisolone therapy in laser injury of the retina | Q36761896 | ||
| The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death | Q37585239 | ||
| Excitatory amino acid neurotoxicity and neurodegenerative disease | Q37989602 | ||
| Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage | Q38201300 | ||
| Pharmacotherapy in spinal cord injury: a critical review of recent developments | Q39249190 | ||
| Secondary mechanisms in neuronal trauma. | Q40599290 | ||
| Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review | Q40789568 | ||
| Autoimmune T cells retard the loss of function in injured rat optic nerves | Q40879317 | ||
| Potential neuroprotective therapy for glaucomatous optic neuropathy | Q41716847 | ||
| Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. | Q43517448 | ||
| Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures | Q48281625 | ||
| Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma | Q48401067 | ||
| High-dose glucocorticoid treatment improves neurological recovery in head-injured mice | Q48482797 | ||
| NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush | Q48616057 | ||
| Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina | Q48699234 | ||
| In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. | Q48765538 | ||
| TUNEL-positive ganglion cells in human primary open-angle glaucoma. | Q50941032 | ||
| Nitric oxide synthase in the human glaucomatous optic nerve head. | Q53971620 | ||
| A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury | Q56775114 | ||
| Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings | Q66887102 | ||
| Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group | Q67660771 | ||
| Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group | Q67702243 | ||
| Comparison of delayed administration of competitive and uncompetitive antagonists in preventing NMDA receptor-mediated neuronal death | Q68086544 | ||
| N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina | Q68126319 | ||
| Protective effects of flunarizine on ischemic injury in the rat retina | Q68140166 | ||
| Dextromethorphan protects retina against ischemic injury in vivo | Q69960583 | ||
| Calcium channel blockers in the management of low-tension and open-angle glaucoma | Q70704896 | ||
| Flunarizine enhances rat retinal ganglion cell survival after axotomy | Q70756785 | ||
| Effect of methylprednisolone in compression trauma to the feline spinal cord | Q70832025 | ||
| A behavioral model of excitotoxicity: retinal degeneration, loss of vision, and subsequent recovery after intraocular NMDA administration in adult rats | Q70841158 | ||
| Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma | Q70999763 | ||
| Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy | Q71004431 | ||
| Brain-derived neurotrophic factor and neurotrophin-4/5 stimulate growth of axonal branches from regenerating retinal ganglion cells | Q71132184 | ||
| Redistribution of GABA immunoreactivity following central retinal artery occlusion | Q71725820 | ||
| Programmed cell death of retinal ganglion cells during experimental glaucoma | Q71735807 | ||
| Prolonged bilateral carotid artery occlusion induces electrophysiological and immunohistochemical changes to the rat retina without causing histological damage | Q71735820 | ||
| Chronic ocular hypertension following episcleral venous occlusion in rats | Q71735886 | ||
| Inflammation after axonal injury has conflicting consequences for recovery of function: rescue of spared axons is impaired but regeneration is supported | Q72755984 | ||
| A rat model of chronic pressure-induced optic nerve damage | Q73202589 | ||
| Flupirtine ameliorates ischaemic-like death of rat retinal ganglion cells by preventing calcium influx | Q73455107 | ||
| Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina | Q73922338 | ||
| Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia | Q74449647 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 447-453 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Brain Research Bulletin | Q4955784 |
| P1476 | title | Neuroprotection in ophthalmology: a review | |
| P478 | volume | 62 |
| Q84558890 | A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein |
| Q34208113 | Aqueous humor hepcidin prohormone levels in patients with primary open angle glaucoma |
| Q26752575 | Citicoline: A Food Beneficial for Patients Suffering from or Threated with Glaucoma |
| Q82988306 | Cortisol promotes survival and regeneration of axotomised retinal ganglion cells and enhances effects of aurintricarboxylic acid |
| Q46925696 | Diazoxide is protective in the rat retina against ischemic injury induced by bilateral carotid occlusion and glutamate-induced degeneration |
| Q45904452 | Diffusion tensor magnetic resonance imaging reveals visual pathway damage that correlates with clinical severity in glaucoma. |
| Q39345466 | Edible seaweed, Eisenia bicyclis, protects retinal ganglion cells death caused by oxidative stress |
| Q34256633 | Effects of combined ketamine/xylazine anesthesia on light induced retinal degeneration in rats. |
| Q28573729 | Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats |
| Q48250501 | L-Satropane Prevents Retinal Neuron Damage by Attenuating Cell Apoptosis and Aβ Production via Activation of M1 Muscarinic Acetylcholine Receptor. |
| Q41997847 | Neurodegenerative diseases of the retina and potential for protection and recovery |
| Q60476041 | Neuroprotection in glaucoma |
| Q90308398 | Neuroprotective Effects of Dried Tubers of Aconitum napellus |
| Q33972545 | The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation. |
| Q53585154 | Toll-like receptor-4 knockout mice are more resistant to optic nerve crush damage than wild-type mice. |
Search more.